Dalteparin for unstable angina and non-Q-wave myocardial infarction. - Suppr | 超能文献

Dalteparin for unstable angina and non-Q-wave myocardial infarction.

作者信息

Borja J

出版信息

Arch Intern Med. 2000 Nov 13;160(20):3169-70. doi: 10.1001/archinte.160.20.3169-a.

DOI:10.1001/archinte.160.20.3169-a

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Dalteparin for unstable angina and non-Q-wave myocardial infarction.

Arch Intern Med. 2000 Nov 13;160(20):3169-70. doi: 10.1001/archinte.160.20.3169-a.

2

[Dalteparin in the acute phase of unstable angina and non-Q-wave infarction].

Rev Esp Cardiol. 2000 Aug;53(8):1147-8.

3

[Low molecular weight heparin in the treatment of acute coronary syndromes without ST-segment elevation: unstable angina and non-Q-wave myocardial infarction].

Med Clin (Barc). 2000 Nov 4;115(15):583-6. doi: 10.1016/s0025-7753(00)71631-9.

4

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis.

Circulation. 1999 Oct 12;100(15):1602-8. doi: 10.1161/01.cir.100.15.1602.

5

Unstable angina and non-Q-wave myocardial infarction. Treatment beyond aspirin and heparin.

Cardiologia. 1999 Dec;44 Suppl 1(Pt 2):799.

6

Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease.

Am J Cardiol. 1997 Sep 4;80(5A):30E-34E. doi: 10.1016/s0002-9149(97)00487-6.

7

Enoxaparin and dalteparin in unstable angina: new indication. Enoxaparin: a reference treatment. Dalteparin: no better than unfractionated heparin.

Prescrire Int. 1999 Jun;8(41):77-80.

8

[Differences in the clinical presentation and prognosis of unstable angina and non-Q wave infarction].

Rev Esp Cardiol. 1999;52 Suppl 1:55-60.

9

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).

Circulation. 1997 Jul 1;96(1):61-8. doi: 10.1161/01.cir.96.1.61.

10

Low-molecular-weight heparins in the management of acute coronary syndromes.

Arch Intern Med. 1999 Sep 13;159(16):1849-57. doi: 10.1001/archinte.159.16.1849.

引用本文的文献

1

Heparin versus placebo for non-ST elevation acute coronary syndromes.

Cochrane Database Syst Rev. 2014 Jun 27;2014(6):CD003462. doi: 10.1002/14651858.CD003462.pub3.